Welcome to the Reuters.com BETA. Read our Editor's note on how we're helping professionals make smart decisions.
Skip to main content

Healthcare & Pharmaceuticals

EU regulator reviewing Moderna COVID shot for auto-immune blood condition

1 minute read

The exterior of the European Medicines Agency is seen in Amsterdam, Netherlands, December 18, 2020. REUTERS/Piroschka van de Wouw

July 14 (Reuters) - Europe's drug regulator said on Wednesday it had assessed nine cases of an auto-immune blood condition following vaccination with Moderna Inc's (MRNA.O) COVID-19 shot, but no "clear causal relationship" could be established between the two.

The European Medicines Agency (EMA) said its safety committee would continue to monitor for cases of immune thrombocytopenia, an auto-immune condition with low blood platelet levels that can lead to bruising and bleeding, with Moderna's vaccine, Spikevax.

Reporting by Pushkala Aripaka in Bengaluru; Editing by Rashmi Aich

Our Standards: The Thomson Reuters Trust Principles.

More from Reuters